TrialBlood cancer journal2026

Zanubrutinib combined with R-CHOP in previously untreated diffuse large B-cell lymphoma with specific gene alteration: a phase II study.

Qunling Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.